Harmony Biosciences Holdings, Inc. (HRMY) › Cash & EquivalentsHarmony Biosciences Holdings, Inc. (HRMY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $24.46M2020: $228.63M2021: $234.31M2022: $243.78M2023: $311.66M2024: $453.00M2025: $752.50M$752.50M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$752.50M+66.1%2024$453.00M+45.4%2023$311.66M+27.8%2022$243.78M+4.0%2021$234.31M+2.5%2020$228.63M+834.8%2019$24.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share